According to the French news agency (AFP), the head of the World Health Organization, Tedros Adhanom, says that the first malaria vaccine has been approved for widespread use worldwide.
It is the first vaccine against the mosquito-borne disease, which kills 400,000 people a year worldwide, including children in African countries.
According to the report, the World Health Organization decided after reviewing a pilot program in Ghana, Kenya, and the Maldives in 2019.
More than 2 million doses of the vaccine were given, first developed by the pharmaceutical company GlaxoSmithKline in 1987.
The World Health Organization (WHO) has recommended the widespread use of the world’s first malaria vaccine after reviewing the results from those countries, said Tedros Adhanom, director-general of the WHO.
The World Health Organization (WHO) said that the vaccine was being used in large numbers in African countries to prevent the spread of mild to severe malaria in children and other regions.
There are many vaccines in the world to prevent various diseases and germs. Still, the World Health Organization has proposed the widespread use of a single vaccine against the human epidemic for the first time.
“From a scientific point of view, this is a huge breakthrough,” said Pedro Alonso, director of the World Health Organization’s Global Malaria Program.
The vaccine works against five types of infectious germs, and most of them, the so-called worst Plasmodium falciparum. But, on the other hand, it is said that the next step will be funding before the proposed vaccine reaches African children.
“This will be the next important step, then we will determine the food supply and decide where the vaccine will be most beneficial and how to get there,” said Kate O’Brien, director of the World Health Organization’s Department of Immunization, Vaccines, and Biology. According to the WHO, one child dies of malaria every two minutes.
